Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 92

Results For "US"

7516 News Found

Zydus receives EIR for injectables manufacturing facility at Zydus Biotech Park, Ahmedabad
News | September 14, 2023

Zydus receives EIR for injectables manufacturing facility at Zydus Biotech Park, Ahmedabad

The inspection was a cGMP Inspection and had ended with NIL observations


President Murmu to virtually launch Ayushman Bhav Campaign today
Policy | September 13, 2023

President Murmu to virtually launch Ayushman Bhav Campaign today

Ayushman Bhav a comprehensive nationwide healthcare initiative ensures saturation coverage of healthcare schemes, reaching every village and town


Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection
Drug Approval | September 12, 2023

Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection

Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management


Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL
News | September 12, 2023

Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL

Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable


JB Pharma publishes sustainability report for FY 2022-23
Sustainability | September 12, 2023

JB Pharma publishes sustainability report for FY 2022-23

JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions


Strides receives USFDA approval for Sevelamer Carbonate for oral suspension
Drug Approval | September 11, 2023

Strides receives USFDA approval for Sevelamer Carbonate for oral suspension

The products will be manufactured at the company's facility in Bengaluru


Fermenta Biotech inaugurates customized premix manufacturing plant in Kullu, Himachal Pradesh
News | September 08, 2023

Fermenta Biotech inaugurates customized premix manufacturing plant in Kullu, Himachal Pradesh

The company will develop and produce premixes for human nutrition applications


Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals
Opinion | September 08, 2023

Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals

This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards


Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
News | September 07, 2023

Biocon Biologics completes integration of Viatris Biosimilars’ business in North America

Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris


Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients
Healthcare | September 07, 2023

Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients

This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US